Vanadium: Pollution, metabolism and genotoxicity;Vanadio: Contaminación, metabolismo y genotoxicidad

Revista Internacional de Contaminacion Ambiental

Volumn 22, Issue 4, 2006, Pages 173-189

  Rodríguez Mercado, Juan José ^a   Altamirano Lozano, Mario Agustín ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cell toxicity; Genotoxic effects; Metals toxicity; Mutagenic effects; Vanadium

Indexed keywords

CELLS; GENES; METABOLISM; POLLUTION DETECTION; TOXICITY; VANADIUM;

CARCINOGEN; CHEMICAL POLLUTANT; GENOTOXICITY; METABOLISM; MUTAGENICITY; TOXIC MATERIAL; VANADIUM;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 33947181448     PISSN: 01884999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Abundis M.H.M. (1994). Valoración de la genotoxicidad del pentóxido de vanadio en células de las alas de Drosophila melanogaster. Comparación de tres protocolos. Tesis de Licenciatura. UNAM, México.
2. Abundis M.H.M. (1996). Determinación de la mutación y recombinación somáticas en la inducción de efectos genotóxicos por tres sales de vanadio en Drosophila melanogaster. Tesis de Maestría. UNAM, México.
3. Alessio L., Marinoni M. y Dell'Orto A. (1988). Biological monitoring of vanadium. En: Biological monitoring of toxic metals. (W.T.Clarkson, L.Friberg, F. Nordberg y R. Sanger, Eds.) Plenum Press, Nueva York, pp. 427-436.
4. Altamirano L.M., Álvarez B.L. y Roldán E.R. (1993). Cytogenetic and teratogenic effects of vanadium pentoxide on mice. Med. Sci. Res. 21, 711-713.
5. Altamirano-Lozano M.A. y Álvarez-Barrera L. (1996). Genotoxic and reprotoxic effects of vanadium and lithium. En: Metal Ions in Biology and Medicine (J. Collery, Ph. Corbella, J.L. Domingo, J.C. Etienne y J.M. Llobert, Eds.). John Libbey Eurotex, París, Vol. 4, pp. 423-425.
6. Altamirano-Lozano M.A., Álvarez-Barrera L., Basurto- Alcántara F., Valverde M. y Rojas E. (1996). Reprotoxic and genotoxic studies of vanadium pentoxide in male mice. Teratogen. Carcinogen. Mutagen. 16, 7-17.
7. 5) in male mice. II. Effects in several mouse tissues. Teratogen. Mutagen. Carcinogen. 19, 243-255.
8. Alessio L., Marinoni M. y Dell'Orto A. (1988). Biological monitoring of vanadium. En: Biological monitoring of toxic metals (W.T. Clarkson, L. Friberg, F. Nordberg y R. Sanger, Eds.). Plenum Press, Nueva York. pp. 427-436.
9. Andrew A.S., Warren A.J., Barchowsky A., Temple K.A., Klei L., Soucy N.V., O'Hara K.A. y Hamilton J.W. (2003). Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environ Health Perspect. 111, 825-835.
10. Aragón M.A., Ayala M.E., Fortoul T.I., Bizarro P. y Altamirano-Lozano M. (2005). Vanadium induced ultrastructural changes and apoptosis in male germ cells. Reprod. Toxicol. 20, 127-134.
11. Attia S.M., Badary O.A., Hamada F.M., Hrabé de Angelis M. y Adler I.D. (2005). Orthovanadate inceased the frequency of aneuploid mouse sperm without micronucleus induction in mouse bone marrow erythrocytes at the same dose level. Mutat. Res. 583, 158-167.
12. Bal W. y Kasprzak K.S. (2002). Induction of oxidative DNA damage by carcinogenic metals. Toxicol. Lett. 127, 55-62.
13. Baran E.J. (2000). Oxovanadium(IV) and oxovanadium(V) complexes relevant to biological systems. J. Inorg. Biochem. 80, 1-10.
14. Baroch E.F. (1983). Vanadium and vanadium alloys. En: Encyclopaedia of chemical technology. Wiley, Nueva York, pp. 673-710.
15. Barrera F.S.M. y Villalobos C.H.D. (1998). Genotoxic effects of vanadyl sulfate in Drosophila melanogaster. Invest. Clin. 39, Suppl. 1, 123-37.
16. Bjelland S. y Seeberg E. (2003). Mutagenicity, toxicity and repair of DNA base damage induced by oxidation. Mutat. Res. 531, 37-80.
17. Bronzetti G., Morchetti E., Della Croce E., del Carratore R., Giromini L. y Galli A. (1990). Vanadium; genetical and biochemical investigations. Mutagenesis 5, 293-295.
18. Budavari S., O'Neil M.J., Smith A., Heckelman P.E. y Kinneary J.F. (1996). The Merck Index. An encyclopedia of chemicals, drugs and biologicals. Edición 12. Whiehouse Station, Merck, Nueva Jersey.
19. Cantley L.C., Cantley L.G. y Josephson L. (1978). Vanadate inhibits the red cell (Na+, K+) ATPase from the cytoplasmic side. Nature 272, 552-4.
20. Carson B.L., Ellis H.V. y McCann J.L. (1987). Toxicology and biological monitoring of metals in humans. Lewis Publishers, Nueva York, pp. 276-289.
21. Ciranni R., Antonetti M. y Migliore L. (1995). Vanadium salts induce cytogenetic effects in vivo treated mice. Mutat. Res. 343, 53-60.
22. Cohen M.D., Klein C.B. y Costa M. (1992). Forward mutations and DNA-protein crosslinks induced by ammonium metavanadate in cultured mammalian cells. Mutat. Res. 269, 141-148.
23. Cooke M.S., Evans M.D., Dizdaroglu M. y Lunec J. (2003). Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 17, 1195-1214.
24. Crans D.C., Robin I. y Theisen L.A. (1989). Interaction of trace levels of vanadium(IV) and vanadium(V) in biological systems. J. Am. Chem. Soc. 111, 7597-7607.
25. Crans D.C., Amin S.S. y Keramidas A.D. (1998). Chemistry of relevance to vanadium in the environment. En: Vanadium in the Environment. Primera parte: Chemistry and Biochemistry (J.O. Nriagu, Ed.). Wiley, Nueva York, pp. 73-96.
26. Crans D.C., Smee J.J., Gaidamauskas E. y Yang L. (2004). The chemistry and biochemistry of vanadium and biological activities exerted by vanadium compounds. Chem. Rev. 104, 849-902.
27. Daley B., Doherty A.T., Fairman B. y Case C.P. (2004). Wear debris from hip or knee replacements causes chromosomal damage in human cells in tissue culture. J. Bone Joint. Surg. Br. 86, 598-606.
28. D'Cruz O.J. y Uckun F.M. (2005). Vaginal contraceptive activity of a chelated vanadocene. Contraception 72, 146-156.
29. Domingo J.L. (1996). Vanadium: a review of the reproductive and developmental toxicity. Reprod. Toxicol. 10, 175-182.
30. EFSA. European Food Safety Authority. (2004). Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on a request from the Commission Related to the Tolerable Upper Intake Level of Vanadium. EFSA J. 33, 1-22.
31. Elinder C.G., Gerhardsson L. y Oberdoerster G. (1988). Biological monitoring of toxic metals-overview. En: Biological monitoring of toxic metals (W.T. Clarkson, L. Friberg, F. Nordberg y R. Sanger, Eds.). Plenum Press, Nueva York, pp. 1-71.
32. Evangelou A.M. (2002). Vanadium in cancer treatment. Crit. Rev. Oncol. Hematol. 42, 249-265.
33. Fickl H., Theron A.J., Grimmer H., Oommen J., Ramafi G.J., Steel H.C., Visser S.S. y Anderson R. (2006). Vanadium promotes hydroxyl radical formation by activated human neutrophils. Free Radic. Biol. Med. 40, 146-155.
34. Fortoul T.I., Quan-Torres A., Sanchez I., Lopez I.E., Bizarro P., Mendoza M.L., Osorio L.S., Espejel-Maya G., Avila-Casado M. del C., Avila-Costa M.R., Colin-Barenque L., Villanueva D.N. y Olaiz-Fernandez G. (2002). Vanadium in ambient air: concentrations in lung tissue from autopsies of Mexico City residents in the 1960s and 1990s. Arch. Environ. Health 57, 446-449.
35. French R.J. y Jones J.H. (1993). Role of vanadium in nutrition: metabolism, essentiality and dietary considerations. Lif. Sci. 52, 339-346.
36. Galli A., Vellosi R., Fiorio R., Della Croce C., del Carratore R., Morichetti E., Giromini L., Rosellini D. y Bronzetti G. (1991). Genotoxicity of vanadium compounds in yeast and cultured mammalian cells. Teratog. Carcinog. Mutagen. 11, 175-183.
37. Gioka C., Bourauel C., Zinelis S., Eliades T., Silikas N. y Eliades G. (2004). Titanium orthodontic brackets: structure, composition, hardness and ionic release. Dent. Mater. 20, 693-700.
38. Giri A.K., Sanyal R., Sharna A. y Talukder G. (1979). Cytological and cytochemical changes induced through certain heavy metals in mammalian systems. Natl. Acad. Sci. Lett. 2, 391-394.
39. Gutiérrez-Castillo M.E., Roubicek D.A., Cebrián-Garcia M.E., De Vizcaya-Ruíz A., Sordo-Cedeño M. y Ostrosky-Wegman P. (2006). Effect of chemical composition on the induction DNA damage by air-borne particulate matter. Environ. Mol. Mutagen. 47, 199-211.
40. Hartwig A. (1995). Current aspects in metal genotoxicity. Biometals 8, 3-11.
41. Hartwig A., Asmuss M., Blessing H., Hoffmann S., Jahnke G., Khandelwal S., Pelzer A. y Burkle A. (2002). Interference by toxic metal ions with zinc-dependent proteins involved in maintaining genomic stability. Food Chem. Toxicol. 40, 1179-1184.
42. Heinz A., Rubinson K.A. y Grantham J.J. (1982). The transport and accumulation of oxovanadium compounds in human erythrocytes in vitro. J. Lab. Clin. Med. 100, 593-612.
43. Hirao T. (2000). Redox reactions via vanadium-induced electron transfer. J. Inorg. Biochem. 80, 27-33.
44. IARC. International Agency for Research on Cancer. (2006). Monographs on the evaluation of carcinogenic risk to humans. Cobalt in hard-metals and cobalt sulfate, gallium arsenide, indium phosphide and vanadium pentoxide. Lyon, Vol. 86.
45. IPCS. International Programme on Chemical Safety. (1988). Vanadium. Environmental Health Criteria, World Health Organisation, Ginebra, No. 81.
46. IPCS. International Programme on Chemical Safety. (2001). Vanadium pentoxide and other inorganic vanadium compounds, World Health Organisation, Ginebra, No. 29.
47. Ivancsits S., Pilger A., Diem E., Schaffer A. y Rüdiger H.W. (2002). Vanadate induces DNA strand breaks in cultured fibroblasts at doses relevant to occupational exposure. Mutat. Res. 519, 25-35.
48. Jackson J.F. y Linskens H.F. (1982). Metal ion induced unscheduled DNA synthesis in Petunia pollen. Mol. Gen. Genet. 187, 112-115.
49. Kada T., Hirano K. y Shirasu Y. (1980). Screening of environmental chemical mutagens by the rec-assay system with Bacillus subtilis. En: Chemical mutagens: Principles and methods for their detection (F.J. de Serres y A. Hollaender, Eds.). Plenum Press, Nueva York, Vol. 5, pp. 149-173.
50. Kanematsu N. y Kada I. (1978). Mutagenicity of metal compounds. Mutat Res. 53, 207-208.
51. Kanematsu N., Hare M. y Kada I. (1980). Rec assay and mutagenicity studies on metal compounds. Mutat. Res. 77, 109-116.
52. Kleinsasser N., Dirschedl P., Staudenmaier R., Harreus U., Wallner B. (2003). Genotoxic effects of vanadium pentoxide on human peripheral lymphocytes and mucosal cells of the upper aerodigestive tract. Int. J. Environ. Health Res. 13, 373-379.
53. Lagerkvist G., Nordberg G.F. y Vouk V. (1986). Vanadium. En: Handbook on the toxicology of metals. Elsevier Science Publishing, Amsterdam, Vol. II, pp. 638-663.
54. Léonard A. (1988). Mechanisms in metal genotoxicity: the significance of in vitro approaches. Mutat. Res. 198, 321-326.
55. Leopardi P., Villani P., Cordelli E., Siniscalchi E., Veschetti E. y Crebelli R. (2005). Assessment of the in vivo genotoxicity of vanadate: analysis of micronuclei and DNA damage induced in mice by oral exposure. Toxicol. Lett. 158, 39-49
56. Lewin B. (2000). Genes VII. Oxford University Press. Oxford, UK.
57. Lin T.S., Chang C.L. y Shen F.M. (2004). Whole blood vanadium in Taiwanese college students. Bull Environ. Contam. Toxicol. 73, 781-786.
58. Mailhes J.B., Hilliard C., Fuseler J.W. y London S.N. (2003). Vanadate, an inhibitor of tyrosine phosphatases, induced premature anaphase in oocytes and aneuploidy and polyploidy in mouse bone marrow cells. Mutat. Res. 538, 101-107.
59. Migliore L., Bocciardi R., Macri C. y Jacono F.L. (1993). Cytogenetic damage induced in human lymphocytes by four vanadium compounds and micronucleus analysis by fluorescence in situ hybridization with a centromeric probe. Mutat. Res. 319, 205-213.
60. Migliore L., Scarpato R., Falco P. (1995). The use of fluorescence in situ hybridization with a beta-satellite DNA probe for the detection of acrocentric chromosomes in vanadium-induced micronuclei. Cytogenet. Cell Genet. 69, 215-219.
61. Migliore L., Zotti-Martelli L. y Scarpato R. (1999). Detection of chromosome loss and gain induced by griseofulvin, estramustine an vanadate in binucleated lymphocytes using FISH analysis. Environ. Mol. Mutagen. 34, 64-68.
62. Miramand P. y Fowler S. (1998). Bioaccumulation and transfer of vanadium in marine organism. En: Vanadium in the environmental. Parte I y II (J.O. Nriagu, Ed.). Wiley, Nueva York.
63. Mukherjee B., Patra B., Mahapatra S., Banerjee P., Tiwari A. y Chatterjee M. (2004). Vanadium-an element of atypical biological significance. Toxicol. Lett 21, 135-143.
64. Narayan R.J. (2005). Nanostructured diamondlike carbon thin films medical applications. Materials Sci. Engin. C 25, 405-416.
65. Navas P., Hidalgo A. y García-Herdugo G. (1986). Cytokinesis in onion roots: inhibition by vanadate and caffeine. Cell. Mol. Life Sc. 42, 437-439.
66. Nechay N.R., Nanninga L.B. y Nechay S.E. (1986). Vanadyl (VI) and vanadate (V) binding to selected endogenous phosphate, carboxyl, and amino ligand; calculations of cellular vanadium species distribution. Arch. Biochem. Biophys. 251, 128-138.
67. a, Nueva York.
68. NTP. National Toxicology Program. (2002). NTP toxicology and carcinogensis studies of vanadium pentoxide (CAS No. 1314-62-1) in F344/N rats and B6C3F1 mice (inhalation). Natl. Toxicol. Program. Tech. Rep. Ser. 507, 1-343.
69. Olin K.L., Cherr G.N., Rifkin E. y Keen C.L. (1996). The effects of some redox-active metals and reactive aldehydes on DNA-protein cross-links in vitro. Toxicology 110, 1-8.
70. Owusu-Yaw J., Choen M.D., Fernando S.Y. y Wei C.I. (1990). An assessment of the genotoxicity of vanadium. Toxicol. Lett. 50, 327-336.
71. Paton G.R. y Allison A.C. (1972). Chromosome damage in human cell cultures induced by metal salts. Mutat. Res. 16, 332-336.
72. Ramírez P., Easstmond D.A., Laclette J.P. y Ostrosky-Wegman P. (1997). Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploidy cells by sodium arsenite and vanadium pentoxide. Mutat. Res. 386, 291-298.
73. Rehder D. (1991). The bioinorganic chemistry of vanadium. Angew. Chem. Int. Ed. Engl. 30, 148-167.
74. Rehder D. (2003). Biological and medicinal aspects of vanadium. Inorg. Chem. Commun. 6, 604-617.
75. Rodríguez-Mercado J.J. (1996). Genotoxicidad inducida in vitro por sales de vanadio en cromosomas de linfocitos humanos. Tesis de Licenciatura, UNAM. México.
76. Rodríguez-Mercado J.J. (2001). Evaluación de los efectos genotóxico y citotóxico inducidos en cultivos de células de sangre periférica expuestos a tetraóxido de vanadio. Tesis de Maestría. UNAM. México.
77. Rodríguez-Mercado J.J., Roldán-Reyes E., Altamirano-Lozano M. (2003). Genotoxic effects of vanadium (IV) in human peripheral blood cells. Toxicol. Lett. 144, 359-369.
78. Rojas E., Valverde M., Herrera L.A., Altamirano-Lozano M.A. y Ostrosky-Wegman P. (1996). Genotoxicity of vanadium pentoxide evaluate by the single cell gel electrophoresis assay in human lymphocytes. Mutat. Res. 359, 77-84.
79. Roldán E. y Altamirano M. (1990). Chromosomal aberrations, sister chromatid exchanges, cell-cycle kinetics and satellite association in human lymphocytes culture exposed to vanadium pentoxide. Mutat. Res. 245, 61-65.
80. Sabbioni E., Pozzi G., Devos S., Pintar A., Casella L. y Fischbach M. (1993). The intensity of vanadium (V)-induced cytotoxicity and morphological transformation in BALB/3T3 cell is dependent on glutathione-mediated bioreduction to vanadium (IV). Carcinogenesis 14, 2565-2568.
81. Sakurai H. (1994). Vanadium distribution in rats and ADN cleavage by vanadyl complex: implication for vanadium toxicity and biological effects. Environ. Health Perspect. 102, 35-36.
82. Scior T., Guevara-Garcia A., Bernard P., Do Q.T., Domeyer D. y Laufer S. (2005). Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review. Mini Rev. Med. Chem. 5, 995-1008.
83. Sharma R.P., Flora J.S., Drown D.B. y Oberg S.G. (1987). Persistence of vanadium compounds in lungs after intracheal instillation in rats. Toxicol. Ind. Health 3, 321-329.
84. Singh O.P. (1979). Effects of certain metallic pollutants on plant chromosomes. Tesis Doctoral. Universidad de Calcuta, India.
85. a ed., Wiley, Nueva York, Vol. II A, pp. 1493-1583.
86. Sun P. (1987). Toxicity of vanadium and its environmental health standard. Reporte de: Changdu West China University of Medical Sciences, China.
87. Thompson K.H. y Orvig C. (2004). Vanadium compounds in the treatment of diabetes. Met. Ions Biol. Syst. 41, 221-252.
88. Valko M., Morris H. y Cronin M.T.D. (2005). Metals, toxicity and oxidative stress. Curr. Med. Chem. 12, 1161-1208.
89. WHO. World Health Organization. (2001). Air quality guidelines for Europe. Copenhague, No. 91.
90. Woodin M.A., Liu Y., Neuberg D., Hauser R., Smith T.J. y Christiani D.C. (2000). Acute respiratory symptoms in workers exposed to vanadium-rich fuel-oil ash. Am. J. Ind. Med. 37, 353-363.
91. Wozniak K. y Blasiak J. (2004). Vanadyl sulfate can differentially damage DNA in human lymphocytes and HeLa cells. Arch. Toxicol. 78, 7-15.
92. Yang X-G., Wang K., Lu J. y Crans D.C. (2003). Membrane transport of vanadium compounds and the interaction with the erythrocyte membrane. Coordination Chem. Res. 237, 103-111.
93. Yang X-G., Yang X-D., Yuan L., Wang K. y Crans D.C. (2004). The permeability and cytotoxicity of insulin-mimetic vanadium compounds. Pharmaceutical Res. 21, 1026-1033.
94. Zhong B.Z., Gu Z.W., Wallace W.E., Whong W.Z. y Ong T. (1994). Genotoxicity of vanadium pentoxide in Chinese hamster V79 cells. Mutat. Res. 321, 35-42.